| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Merkel Cell | 31 | 2024 | 328 | 10.430 |
Why?
|
| Polyomavirus Infections | 18 | 2023 | 194 | 6.730 |
Why?
|
| Tumor Virus Infections | 18 | 2023 | 438 | 5.610 |
Why?
|
| Antigens, Polyomavirus Transforming | 33 | 2022 | 257 | 4.360 |
Why?
|
| Simian virus 40 | 24 | 2022 | 291 | 3.930 |
Why?
|
| Antigens, Viral, Tumor | 15 | 2022 | 153 | 3.400 |
Why?
|
| Retinoblastoma Protein | 40 | 2019 | 672 | 3.020 |
Why?
|
| Cell Cycle Proteins | 38 | 2022 | 3448 | 2.940 |
Why?
|
| Skin Neoplasms | 26 | 2024 | 5821 | 2.880 |
Why?
|
| Cell Cycle | 41 | 2022 | 2932 | 2.220 |
Why?
|
| Polyomavirus | 9 | 2022 | 234 | 2.000 |
Why?
|
| Cell Transformation, Viral | 11 | 2020 | 526 | 1.840 |
Why?
|
| Tumor Suppressor Protein p53 | 21 | 2022 | 2917 | 1.630 |
Why?
|
| Kv Channel-Interacting Proteins | 7 | 2021 | 40 | 1.630 |
Why?
|
| Retinoblastoma-Like Protein p130 | 14 | 2019 | 73 | 1.540 |
Why?
|
| Cullin Proteins | 9 | 2018 | 179 | 1.430 |
Why?
|
| Mitosis | 9 | 2022 | 1187 | 1.330 |
Why?
|
| Immunoprecipitation | 3 | 2020 | 878 | 1.300 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 4 | 2022 | 368 | 1.240 |
Why?
|
| Repressor Proteins | 12 | 2022 | 2986 | 1.220 |
Why?
|
| Proteins | 16 | 2020 | 6032 | 1.150 |
Why?
|
| Trans-Activators | 13 | 2021 | 2856 | 1.110 |
Why?
|
| Nuclear Proteins | 30 | 2020 | 5796 | 1.050 |
Why?
|
| DNA, Viral | 7 | 2020 | 2202 | 1.050 |
Why?
|
| Antigens | 4 | 2020 | 1443 | 1.040 |
Why?
|
| Phosphoproteins | 20 | 2020 | 2448 | 1.040 |
Why?
|
| Carrier Proteins | 21 | 2012 | 4936 | 0.870 |
Why?
|
| Cell Transformation, Neoplastic | 14 | 2022 | 2825 | 0.820 |
Why?
|
| Retinoblastoma-Like Protein p107 | 7 | 2019 | 71 | 0.800 |
Why?
|
| Ubiquitin-Protein Ligases | 11 | 2021 | 1897 | 0.780 |
Why?
|
| DNA Helicases | 6 | 2018 | 851 | 0.780 |
Why?
|
| DNA-Binding Proteins | 29 | 2018 | 9606 | 0.750 |
Why?
|
| BK Virus | 1 | 2022 | 123 | 0.740 |
Why?
|
| Gene Expression Regulation, Neoplastic | 16 | 2021 | 8547 | 0.720 |
Why?
|
| Transcription Factors | 34 | 2021 | 12128 | 0.710 |
Why?
|
| F-Box Proteins | 3 | 2012 | 201 | 0.700 |
Why?
|
| Host-Pathogen Interactions | 5 | 2017 | 1459 | 0.690 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2020 | 125 | 0.680 |
Why?
|
| Cyclin D | 2 | 2019 | 72 | 0.680 |
Why?
|
| Protein Denaturation | 1 | 2020 | 242 | 0.680 |
Why?
|
| Tumor Suppressor Proteins | 11 | 2014 | 2803 | 0.660 |
Why?
|
| Detergents | 1 | 2020 | 236 | 0.660 |
Why?
|
| 5' Untranslated Regions | 1 | 2020 | 256 | 0.660 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2018 | 100 | 0.640 |
Why?
|
| Antigen-Antibody Complex | 1 | 2020 | 510 | 0.630 |
Why?
|
| Pyrazines | 2 | 2021 | 1201 | 0.610 |
Why?
|
| Open Reading Frames | 2 | 2020 | 815 | 0.590 |
Why?
|
| Protein Binding | 35 | 2020 | 9351 | 0.580 |
Why?
|
| E2F4 Transcription Factor | 6 | 2014 | 32 | 0.570 |
Why?
|
| Cell Line | 35 | 2023 | 15601 | 0.570 |
Why?
|
| Host Specificity | 2 | 2018 | 57 | 0.570 |
Why?
|
| Cyclin-Dependent Kinase 4 | 7 | 2019 | 561 | 0.560 |
Why?
|
| Gene Expression Regulation | 19 | 2021 | 11903 | 0.540 |
Why?
|
| Cyclins | 11 | 2016 | 594 | 0.530 |
Why?
|
| Schizosaccharomyces pombe Proteins | 4 | 2013 | 179 | 0.530 |
Why?
|
| Multiprotein Complexes | 7 | 2021 | 1118 | 0.520 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 9 | 2020 | 1741 | 0.510 |
Why?
|
| Blotting, Western | 15 | 2020 | 5035 | 0.510 |
Why?
|
| Forkhead Transcription Factors | 3 | 2013 | 1616 | 0.510 |
Why?
|
| Genome, Viral | 3 | 2021 | 667 | 0.500 |
Why?
|
| Phosphorylation | 37 | 2021 | 8320 | 0.500 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2021 | 5671 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2017 | 988 | 0.490 |
Why?
|
| Anilides | 1 | 2018 | 411 | 0.480 |
Why?
|
| Phosphates | 1 | 2018 | 770 | 0.480 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2015 | 211 | 0.470 |
Why?
|
| Ubiquitination | 5 | 2018 | 1006 | 0.470 |
Why?
|
| S Phase | 8 | 2022 | 421 | 0.460 |
Why?
|
| Pyrazoles | 3 | 2021 | 2009 | 0.460 |
Why?
|
| Cell Proliferation | 12 | 2022 | 10445 | 0.450 |
Why?
|
| DNA Replication | 12 | 2022 | 1418 | 0.450 |
Why?
|
| Organogenesis | 1 | 2015 | 215 | 0.450 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2013 | 109 | 0.440 |
Why?
|
| RNA, Viral | 2 | 2020 | 2846 | 0.440 |
Why?
|
| Hot Temperature | 1 | 2020 | 1440 | 0.430 |
Why?
|
| Antibodies | 2 | 2020 | 2418 | 0.410 |
Why?
|
| Cells, Cultured | 19 | 2020 | 18965 | 0.410 |
Why?
|
| Glycolysis | 1 | 2016 | 835 | 0.410 |
Why?
|
| Human papillomavirus 16 | 2 | 2013 | 267 | 0.410 |
Why?
|
| E2F Transcription Factors | 13 | 2021 | 269 | 0.400 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2012 | 25 | 0.400 |
Why?
|
| Humans | 149 | 2024 | 761504 | 0.400 |
Why?
|
| cdc25 Phosphatases | 2 | 2004 | 60 | 0.400 |
Why?
|
| G1 Phase | 8 | 2022 | 403 | 0.400 |
Why?
|
| CREB-Binding Protein | 6 | 2006 | 148 | 0.390 |
Why?
|
| Immunoblotting | 5 | 2020 | 1646 | 0.390 |
Why?
|
| Arabidopsis | 1 | 2015 | 465 | 0.390 |
Why?
|
| Animals | 74 | 2022 | 168459 | 0.380 |
Why?
|
| Benzamides | 2 | 2014 | 1370 | 0.380 |
Why?
|
| Growth Substances | 3 | 2013 | 768 | 0.380 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2018 | 4511 | 0.380 |
Why?
|
| Protein Structure, Tertiary | 12 | 2012 | 3792 | 0.370 |
Why?
|
| Phosphoprotein Phosphatases | 4 | 2020 | 329 | 0.360 |
Why?
|
| Molecular Sequence Data | 33 | 2014 | 17635 | 0.360 |
Why?
|
| Viruses | 3 | 2023 | 375 | 0.360 |
Why?
|
| Mutation | 23 | 2023 | 30052 | 0.350 |
Why?
|
| Receptors, Virus | 2 | 2012 | 640 | 0.350 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2022 | 2425 | 0.350 |
Why?
|
| Transfection | 21 | 2019 | 5774 | 0.350 |
Why?
|
| Pyridines | 2 | 2022 | 2875 | 0.350 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 2199 | 0.340 |
Why?
|
| Adenoviridae | 4 | 2012 | 1084 | 0.340 |
Why?
|
| Genes, Retinoblastoma | 6 | 2009 | 125 | 0.340 |
Why?
|
| Retinoblastoma Binding Proteins | 3 | 2021 | 101 | 0.330 |
Why?
|
| Virus Integration | 3 | 2021 | 304 | 0.320 |
Why?
|
| Cyclin-Dependent Kinases | 7 | 2022 | 655 | 0.310 |
Why?
|
| Cyclin E | 5 | 2016 | 156 | 0.310 |
Why?
|
| Retinoblastoma | 6 | 2009 | 317 | 0.300 |
Why?
|
| Immunization | 3 | 2021 | 1228 | 0.300 |
Why?
|
| Cell Line, Tumor | 16 | 2020 | 16981 | 0.300 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2023 | 2872 | 0.300 |
Why?
|
| Schizosaccharomyces | 4 | 2013 | 238 | 0.300 |
Why?
|
| DNA Damage | 5 | 2020 | 2446 | 0.290 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2007 | 39 | 0.290 |
Why?
|
| Transcription Factor DP1 | 11 | 2011 | 136 | 0.290 |
Why?
|
| HeLa Cells | 9 | 2016 | 3093 | 0.290 |
Why?
|
| Poliovirus Vaccines | 1 | 2006 | 13 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2020 | 2898 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2020 | 4026 | 0.270 |
Why?
|
| Piperazines | 2 | 2014 | 2523 | 0.270 |
Why?
|
| Amino Acid Sequence | 27 | 2014 | 13446 | 0.270 |
Why?
|
| Virus Replication | 4 | 2018 | 2435 | 0.270 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 954 | 0.270 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2004 | 370 | 0.270 |
Why?
|
| Mice | 44 | 2022 | 81525 | 0.270 |
Why?
|
| Fibroblasts | 12 | 2021 | 4141 | 0.270 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 13639 | 0.260 |
Why?
|
| Fetal Growth Retardation | 2 | 2007 | 580 | 0.260 |
Why?
|
| Genes, cdc | 2 | 2019 | 114 | 0.260 |
Why?
|
| Cell Division | 18 | 2005 | 4465 | 0.260 |
Why?
|
| NIH 3T3 Cells | 5 | 2011 | 670 | 0.260 |
Why?
|
| Pyrimidines | 3 | 2019 | 3028 | 0.260 |
Why?
|
| DNA Topoisomerase IV | 1 | 2005 | 42 | 0.250 |
Why?
|
| Down-Regulation | 4 | 2019 | 2919 | 0.250 |
Why?
|
| Drug Contamination | 1 | 2006 | 152 | 0.250 |
Why?
|
| Binding Sites | 21 | 2012 | 6055 | 0.250 |
Why?
|
| Fluoroquinolones | 1 | 2007 | 307 | 0.240 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2005 | 175 | 0.240 |
Why?
|
| Eye Neoplasms | 4 | 1990 | 307 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3612 | 0.230 |
Why?
|
| Transcription Factor TFIID | 1 | 2004 | 150 | 0.220 |
Why?
|
| Cell Nucleus | 8 | 2018 | 2909 | 0.220 |
Why?
|
| Mammals | 3 | 2022 | 1132 | 0.220 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2004 | 103 | 0.220 |
Why?
|
| Pandemics | 4 | 2023 | 8654 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 9 | 2016 | 5789 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 10 | 2021 | 9177 | 0.210 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2012 | 1062 | 0.210 |
Why?
|
| Virology | 1 | 2023 | 75 | 0.210 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2004 | 411 | 0.210 |
Why?
|
| Growth Disorders | 1 | 2007 | 655 | 0.210 |
Why?
|
| Cyclohexylamines | 1 | 2022 | 21 | 0.200 |
Why?
|
| Endopeptidases | 2 | 2003 | 774 | 0.200 |
Why?
|
| Collodion | 2 | 2019 | 34 | 0.200 |
Why?
|
| Gene Deletion | 5 | 2019 | 2665 | 0.200 |
Why?
|
| Virus Diseases | 2 | 2023 | 718 | 0.200 |
Why?
|
| Neoplasms | 8 | 2023 | 22170 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5315 | 0.200 |
Why?
|
| Precipitin Tests | 10 | 2005 | 814 | 0.200 |
Why?
|
| DNA Viruses | 1 | 2021 | 34 | 0.200 |
Why?
|
| Insulinoma | 1 | 2022 | 121 | 0.200 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 10 | 2000 | 138 | 0.190 |
Why?
|
| Adenovirus E1A Proteins | 5 | 2009 | 73 | 0.190 |
Why?
|
| Cytoplasm | 3 | 2002 | 1510 | 0.190 |
Why?
|
| RNA, Small Interfering | 7 | 2019 | 3429 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 2020 | 0.190 |
Why?
|
| HIV-1 | 1 | 2019 | 6863 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 20 | 2019 | 6132 | 0.190 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 1999 | 397 | 0.190 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2013 | 495 | 0.180 |
Why?
|
| Protein Kinases | 1 | 2008 | 1608 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2021 | 360 | 0.180 |
Why?
|
| Pyrrolidines | 1 | 2022 | 338 | 0.180 |
Why?
|
| Oncogene Proteins, Viral | 6 | 2014 | 340 | 0.180 |
Why?
|
| Tromethamine | 1 | 2020 | 31 | 0.180 |
Why?
|
| Embryonic Development | 1 | 2005 | 721 | 0.180 |
Why?
|
| Genomic Instability | 2 | 2021 | 709 | 0.170 |
Why?
|
| Heat-Shock Proteins | 5 | 1998 | 795 | 0.170 |
Why?
|
| Antibody Affinity | 1 | 2020 | 246 | 0.170 |
Why?
|
| Histone Acetyltransferases | 4 | 2014 | 336 | 0.170 |
Why?
|
| Enzyme Inhibitors | 4 | 2007 | 3712 | 0.170 |
Why?
|
| Interphase | 3 | 1999 | 228 | 0.170 |
Why?
|
| Meiosis | 2 | 2001 | 328 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2021 | 3639 | 0.170 |
Why?
|
| Growth Inhibitors | 2 | 1998 | 378 | 0.170 |
Why?
|
| Signal Transduction | 17 | 2022 | 23445 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 11 | 2004 | 3734 | 0.160 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 9420 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase 2 | 3 | 2016 | 184 | 0.160 |
Why?
|
| Amino Acid Motifs | 4 | 2013 | 931 | 0.160 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 1886 | 0.160 |
Why?
|
| Embryo, Mammalian | 6 | 2014 | 1675 | 0.160 |
Why?
|
| Acetylation | 3 | 2006 | 1055 | 0.160 |
Why?
|
| Fungal Proteins | 3 | 2001 | 910 | 0.150 |
Why?
|
| Feedback, Physiological | 2 | 2016 | 476 | 0.150 |
Why?
|
| Suppression, Genetic | 2 | 2007 | 190 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2024 | 2057 | 0.150 |
Why?
|
| Base Sequence | 18 | 2011 | 12441 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 8 | 2007 | 2748 | 0.150 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2001 | 1841 | 0.150 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 212 | 0.150 |
Why?
|
| Survival Analysis | 5 | 2020 | 10090 | 0.150 |
Why?
|
| Polyvinyls | 1 | 2018 | 154 | 0.150 |
Why?
|
| Blood Vessels | 1 | 2003 | 1113 | 0.150 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 339 | 0.140 |
Why?
|
| Mucin-1 | 1 | 2022 | 540 | 0.140 |
Why?
|
| G2 Phase | 2 | 2014 | 136 | 0.140 |
Why?
|
| RNA Splicing | 1 | 2022 | 918 | 0.140 |
Why?
|
| Apoptosis | 9 | 2020 | 9486 | 0.140 |
Why?
|
| Transferases | 2 | 2007 | 72 | 0.140 |
Why?
|
| Gene Expression | 4 | 2022 | 7581 | 0.140 |
Why?
|
| Antiviral Agents | 2 | 2023 | 3060 | 0.140 |
Why?
|
| E2F1 Transcription Factor | 3 | 2015 | 178 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13380 | 0.140 |
Why?
|
| Oncogene Proteins | 4 | 2016 | 718 | 0.140 |
Why?
|
| Phylogeny | 4 | 2020 | 2811 | 0.130 |
Why?
|
| Mice, Knockout | 7 | 2019 | 14414 | 0.130 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2018 | 439 | 0.130 |
Why?
|
| Genomics | 3 | 2021 | 5821 | 0.130 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 545 | 0.130 |
Why?
|
| Oncogene Protein p21(ras) | 2 | 2014 | 68 | 0.130 |
Why?
|
| Paraganglioma, Extra-Adrenal | 2 | 2012 | 45 | 0.120 |
Why?
|
| DNA, Neoplasm | 2 | 2020 | 1745 | 0.120 |
Why?
|
| Cell Line, Transformed | 4 | 2008 | 867 | 0.120 |
Why?
|
| HEK293 Cells | 5 | 2020 | 4278 | 0.120 |
Why?
|
| Oncogenes | 2 | 2012 | 1222 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2022 | 901 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 1010 | 0.120 |
Why?
|
| Glomus Tumor | 2 | 2012 | 62 | 0.120 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 58976 | 0.120 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 2 | 2005 | 88 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 22169 | 0.120 |
Why?
|
| Homeodomain Proteins | 2 | 2022 | 2416 | 0.120 |
Why?
|
| Protein Phosphatase 2 | 2 | 2014 | 231 | 0.120 |
Why?
|
| Research | 1 | 2023 | 1982 | 0.120 |
Why?
|
| Culture Techniques | 1 | 1995 | 531 | 0.120 |
Why?
|
| Papilloma | 1 | 2015 | 140 | 0.110 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2014 | 110 | 0.110 |
Why?
|
| Sequence Deletion | 4 | 2006 | 1494 | 0.110 |
Why?
|
| Indoles | 1 | 2022 | 1833 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2020 | 1974 | 0.110 |
Why?
|
| Animals, Newborn | 4 | 2014 | 2678 | 0.110 |
Why?
|
| RNA Interference | 4 | 2019 | 2831 | 0.110 |
Why?
|
| Bacterial Capsules | 1 | 2015 | 244 | 0.110 |
Why?
|
| Neoplasm Proteins | 6 | 2009 | 3617 | 0.110 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 613 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 3 | 2022 | 5368 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1229 | 0.110 |
Why?
|
| Genome, Human | 2 | 2020 | 4425 | 0.110 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2019 | 1640 | 0.110 |
Why?
|
| Seroepidemiologic Studies | 1 | 2014 | 397 | 0.110 |
Why?
|
| Phenotype | 4 | 2019 | 16591 | 0.110 |
Why?
|
| Transcription, Genetic | 4 | 2017 | 7594 | 0.100 |
Why?
|
| Oncogenic Viruses | 1 | 2012 | 37 | 0.100 |
Why?
|
| Breast | 1 | 2021 | 1967 | 0.100 |
Why?
|
| Viral Tropism | 1 | 2013 | 102 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2000 | 698 | 0.100 |
Why?
|
| Protein Subunits | 3 | 2014 | 943 | 0.100 |
Why?
|
| Cyclin B2 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2022 | 1654 | 0.100 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2012 | 97 | 0.100 |
Why?
|
| CDC2-CDC28 Kinases | 2 | 2003 | 110 | 0.100 |
Why?
|
| Macromolecular Substances | 3 | 2004 | 1434 | 0.100 |
Why?
|
| Male | 17 | 2021 | 360804 | 0.100 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2011 | 12 | 0.100 |
Why?
|
| Structure-Activity Relationship | 3 | 2012 | 3076 | 0.100 |
Why?
|
| HCT116 Cells | 2 | 2016 | 404 | 0.100 |
Why?
|
| 3T3 Cells | 7 | 1999 | 1085 | 0.090 |
Why?
|
| Female | 20 | 2021 | 392644 | 0.090 |
Why?
|
| Hybridomas | 2 | 2021 | 442 | 0.090 |
Why?
|
| Dendritic Cells | 2 | 2020 | 2747 | 0.090 |
Why?
|
| Nuclear Localization Signals | 2 | 2002 | 77 | 0.090 |
Why?
|
| Cyclin B | 2 | 2001 | 104 | 0.090 |
Why?
|
| HSP40 Heat-Shock Proteins | 4 | 1998 | 83 | 0.090 |
Why?
|
| Aged | 10 | 2021 | 169289 | 0.090 |
Why?
|
| Lysine | 2 | 2006 | 993 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 370 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1626 | 0.090 |
Why?
|
| Primates | 1 | 2013 | 523 | 0.090 |
Why?
|
| Computational Biology | 3 | 2020 | 3518 | 0.090 |
Why?
|
| Dimerization | 2 | 2005 | 891 | 0.090 |
Why?
|
| Epithelium | 1 | 2015 | 1603 | 0.090 |
Why?
|
| Simplexvirus | 1 | 2013 | 803 | 0.090 |
Why?
|
| Capsid Proteins | 2 | 2006 | 468 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2455 | 0.080 |
Why?
|
| Plakophilins | 1 | 2008 | 32 | 0.080 |
Why?
|
| Immunotherapy | 3 | 2020 | 4652 | 0.080 |
Why?
|
| Chondrocytes | 1 | 2014 | 795 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 3 | 2016 | 2811 | 0.080 |
Why?
|
| Ligases | 2 | 2003 | 333 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4544 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 1989 | 373 | 0.080 |
Why?
|
| 14-3-3 Proteins | 3 | 2004 | 220 | 0.080 |
Why?
|
| Antibodies, Viral | 2 | 2012 | 3156 | 0.080 |
Why?
|
| Middle Aged | 9 | 2021 | 220895 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2012 | 1804 | 0.080 |
Why?
|
| Plasmids | 4 | 2014 | 2269 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2012 | 1217 | 0.080 |
Why?
|
| Enzyme Activation | 4 | 2016 | 3597 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1896 | 0.080 |
Why?
|
| Conserved Sequence | 2 | 2011 | 1163 | 0.080 |
Why?
|
| Placenta | 3 | 2007 | 1709 | 0.070 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2008 | 85 | 0.070 |
Why?
|
| Ribonucleotides | 1 | 2008 | 114 | 0.070 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2007 | 9 | 0.070 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 611 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2010 | 449 | 0.070 |
Why?
|
| DNA Primers | 3 | 1997 | 2819 | 0.070 |
Why?
|
| Multigene Family | 2 | 2004 | 1076 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1745 | 0.070 |
Why?
|
| Prostatic Neoplasms | 2 | 2021 | 11118 | 0.070 |
Why?
|
| Genetic Complementation Test | 2 | 2006 | 554 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 617 | 0.070 |
Why?
|
| Genes, p16 | 2 | 1997 | 160 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1659 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2017 | 855 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1509 | 0.070 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2007 | 151 | 0.070 |
Why?
|
| Biological Evolution | 1 | 2013 | 1071 | 0.070 |
Why?
|
| Mutagenesis | 4 | 2012 | 1232 | 0.070 |
Why?
|
| Ofloxacin | 1 | 2007 | 66 | 0.070 |
Why?
|
| B-Lymphocytes | 3 | 2019 | 4758 | 0.070 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2006 | 24 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2018 | 5247 | 0.070 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 2006 | 25 | 0.070 |
Why?
|
| Retinal Neoplasms | 1 | 2009 | 146 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3537 | 0.070 |
Why?
|
| Disease | 1 | 2012 | 672 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 489 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.070 |
Why?
|
| Glutathione Transferase | 4 | 2003 | 565 | 0.070 |
Why?
|
| Adult | 10 | 2022 | 221177 | 0.070 |
Why?
|
| Sequence Homology | 1 | 2006 | 196 | 0.070 |
Why?
|
| Transcriptional Activation | 6 | 2011 | 1756 | 0.070 |
Why?
|
| T-Lymphocytes | 6 | 1997 | 10194 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2013 | 427 | 0.070 |
Why?
|
| Naphthyridines | 1 | 2007 | 143 | 0.060 |
Why?
|
| Genotype | 3 | 2020 | 12990 | 0.060 |
Why?
|
| Stem Cells | 1 | 2018 | 3522 | 0.060 |
Why?
|
| Subcellular Fractions | 3 | 2003 | 532 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 656 | 0.060 |
Why?
|
| Okadaic Acid | 2 | 2003 | 67 | 0.060 |
Why?
|
| Cricetinae | 3 | 2004 | 2423 | 0.060 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2018 | 452 | 0.060 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2004 | 12 | 0.060 |
Why?
|
| COS Cells | 2 | 2004 | 1130 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 4111 | 0.060 |
Why?
|
| Ciprofloxacin | 1 | 2007 | 312 | 0.060 |
Why?
|
| Cell Compartmentation | 3 | 2002 | 384 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2004 | 1320 | 0.060 |
Why?
|
| Models, Biological | 4 | 2012 | 9469 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 4740 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2019 | 1749 | 0.050 |
Why?
|
| Maltose-Binding Proteins | 1 | 2003 | 62 | 0.050 |
Why?
|
| Aminopeptidases | 1 | 2003 | 95 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 1999 | 1246 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11742 | 0.050 |
Why?
|
| DNA, Fungal | 2 | 2013 | 275 | 0.050 |
Why?
|
| Cell-Free System | 1 | 2003 | 340 | 0.050 |
Why?
|
| Anaphase | 1 | 2003 | 114 | 0.050 |
Why?
|
| Proteomics | 1 | 2016 | 3849 | 0.050 |
Why?
|
| Multiple Myeloma | 5 | 1999 | 5146 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2004 | 1699 | 0.050 |
Why?
|
| Merkel Cells | 1 | 2022 | 24 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 6075 | 0.050 |
Why?
|
| Flow Cytometry | 4 | 2013 | 5869 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 10766 | 0.050 |
Why?
|
| Cloning, Molecular | 7 | 2004 | 4174 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2008 | 3087 | 0.050 |
Why?
|
| Vidarabine | 1 | 2003 | 336 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 2 | 2013 | 213 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2004 | 712 | 0.050 |
Why?
|
| Adolescent | 4 | 2021 | 88319 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2002 | 328 | 0.050 |
Why?
|
| Azepines | 1 | 2003 | 329 | 0.050 |
Why?
|
| Cyclin A | 1 | 2001 | 60 | 0.050 |
Why?
|
| Telomerase | 2 | 2003 | 745 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2012 | 200 | 0.050 |
Why?
|
| Microinjections | 1 | 2002 | 321 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2645 | 0.050 |
Why?
|
| Contact Inhibition | 1 | 2000 | 46 | 0.050 |
Why?
|
| Gamma Rays | 2 | 2019 | 318 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2003 | 1060 | 0.050 |
Why?
|
| Sirolimus | 1 | 2008 | 1533 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 148 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2000 | 84 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4575 | 0.040 |
Why?
|
| Serine | 1 | 2004 | 830 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 11076 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2002 | 1529 | 0.040 |
Why?
|
| Caspases | 1 | 2003 | 879 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2003 | 838 | 0.040 |
Why?
|
| Freeze Drying | 1 | 2019 | 101 | 0.040 |
Why?
|
| Temperature | 2 | 2004 | 2226 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1971 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 2003 | 1991 | 0.040 |
Why?
|
| Mimosine | 1 | 1999 | 7 | 0.040 |
Why?
|
| Proteome | 2 | 2007 | 1862 | 0.040 |
Why?
|
| Kenya | 1 | 2022 | 758 | 0.040 |
Why?
|
| Cell Survival | 2 | 2008 | 5791 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 9280 | 0.040 |
Why?
|
| Disease Susceptibility | 4 | 1990 | 1787 | 0.040 |
Why?
|
| Cyclin B1 | 1 | 1999 | 58 | 0.040 |
Why?
|
| Calcineurin | 1 | 2000 | 229 | 0.040 |
Why?
|
| Child | 2 | 2020 | 80153 | 0.040 |
Why?
|
| Cell Count | 2 | 2000 | 1835 | 0.040 |
Why?
|
| Policy Making | 1 | 2023 | 542 | 0.040 |
Why?
|
| Electricity | 1 | 2019 | 181 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2022 | 1152 | 0.040 |
Why?
|
| Histone Deacetylases | 2 | 2002 | 719 | 0.040 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1999 | 174 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2019 | 26198 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2020 | 233 | 0.040 |
Why?
|
| DNA | 6 | 2003 | 7212 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 3802 | 0.040 |
Why?
|
| Receptors, Steroid | 1 | 1999 | 156 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 12148 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 371 | 0.040 |
Why?
|
| Crystallography, X-Ray | 3 | 2012 | 1990 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 1712 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2007 | 1456 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4915 | 0.040 |
Why?
|
| Epigenomics | 1 | 2023 | 943 | 0.040 |
Why?
|
| Leukemia, Plasma Cell | 1 | 1997 | 46 | 0.040 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 1997 | 49 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 857 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 1999 | 271 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 1997 | 3208 | 0.030 |
Why?
|
| Telomere | 1 | 2003 | 943 | 0.030 |
Why?
|
| Epitopes | 2 | 2021 | 2503 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2009 | 6346 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2012 | 460 | 0.030 |
Why?
|
| Capsid | 1 | 1999 | 435 | 0.030 |
Why?
|
| Time Factors | 4 | 2016 | 39967 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 2 | 2012 | 1078 | 0.030 |
Why?
|
| RNA, Messenger | 5 | 2006 | 12795 | 0.030 |
Why?
|
| Models, Chemical | 2 | 2012 | 611 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 1997 | 439 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 1996 | 1961 | 0.030 |
Why?
|
| Protein Transport | 1 | 2002 | 1967 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 1996 | 143 | 0.030 |
Why?
|
| Zea mays | 1 | 1996 | 112 | 0.030 |
Why?
|
| Lentivirus | 1 | 2019 | 508 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 2141 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1996 | 2186 | 0.030 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 285 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1998 | 579 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1997 | 1551 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2016 | 259 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1136 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 1784 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1612 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1076 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1996 | 226 | 0.030 |
Why?
|
| Prognosis | 2 | 2020 | 29625 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 551 | 0.030 |
Why?
|
| Harmine | 1 | 2014 | 11 | 0.030 |
Why?
|
| Models, Genetic | 3 | 2002 | 3442 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2023 | 1126 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 789 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1997 | 666 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 6216 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1996 | 647 | 0.030 |
Why?
|
| Pregnancy | 2 | 2007 | 29874 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1093 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1405 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 1999 | 897 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 54425 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2016 | 350 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 794 | 0.030 |
Why?
|
| Chromatin | 2 | 2021 | 2960 | 0.030 |
Why?
|
| Adenine | 1 | 2019 | 987 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1997 | 2180 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15266 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1997 | 1880 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 1410 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 59243 | 0.030 |
Why?
|
| Disease Progression | 2 | 2020 | 13506 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12690 | 0.030 |
Why?
|
| Ethers, Cyclic | 1 | 1992 | 32 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 36192 | 0.030 |
Why?
|
| Hydroxyurea | 2 | 1993 | 284 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 17351 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2016 | 1755 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1992 | 262 | 0.020 |
Why?
|
| Histone Demethylases | 1 | 2014 | 320 | 0.020 |
Why?
|
| Rats | 4 | 2000 | 23742 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 42230 | 0.020 |
Why?
|
| ras Proteins | 1 | 1997 | 1054 | 0.020 |
Why?
|
| Plasminogen Inactivators | 1 | 1991 | 37 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 169 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 3 | 1997 | 123 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2019 | 3395 | 0.020 |
Why?
|
| Bacteria | 1 | 2022 | 2199 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 1996 | 6534 | 0.020 |
Why?
|
| Haplorhini | 2 | 1989 | 525 | 0.020 |
Why?
|
| Blast Crisis | 1 | 1991 | 102 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2003 | 319 | 0.020 |
Why?
|
| Papillomaviridae | 2 | 2012 | 1119 | 0.020 |
Why?
|
| Cyclin D2 | 2 | 2003 | 98 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3422 | 0.020 |
Why?
|
| Cell Death | 2 | 2013 | 1678 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 1393 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 75 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1991 | 641 | 0.020 |
Why?
|
| Piperidines | 1 | 2019 | 1656 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 1997 | 1067 | 0.020 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1991 | 284 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6484 | 0.020 |
Why?
|
| Jurkat Cells | 2 | 2002 | 740 | 0.020 |
Why?
|
| Leucovorin | 1 | 1991 | 643 | 0.020 |
Why?
|
| Fanconi Anemia | 1 | 2012 | 324 | 0.020 |
Why?
|
| DNA Repair | 1 | 2019 | 2045 | 0.020 |
Why?
|
| Cyclin D1 | 3 | 1997 | 451 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64680 | 0.020 |
Why?
|
| Stromal Cells | 2 | 2009 | 1330 | 0.020 |
Why?
|
| von Hippel-Lindau Disease | 2 | 2004 | 151 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3384 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2020 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1996 | 779 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 662 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20098 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2003 | 283 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2004 | 305 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 870 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1993 | 1080 | 0.020 |
Why?
|
| Tibia | 1 | 2014 | 1070 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1791 | 0.020 |
Why?
|
| Incidence | 1 | 2006 | 21353 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2012 | 743 | 0.020 |
Why?
|
| Models, Animal | 1 | 2014 | 2112 | 0.020 |
Why?
|
| Fetus | 1 | 1995 | 1863 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1995 | 3968 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2004 | 1545 | 0.020 |
Why?
|
| Fibronectins | 1 | 1991 | 723 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2014 | 1273 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1991 | 1641 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 2580 | 0.020 |
Why?
|
| Lymphocytes | 3 | 2002 | 2612 | 0.020 |
Why?
|
| Adenovirus Early Proteins | 3 | 1991 | 57 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11121 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10508 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 1997 | 5486 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2000 | 3482 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12725 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 745 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14666 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1997 | 461 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17904 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2004 | 366 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1991 | 4853 | 0.010 |
Why?
|
| Cobalt | 1 | 2003 | 154 | 0.010 |
Why?
|
| Cyclohexanes | 1 | 2003 | 152 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2003 | 58 | 0.010 |
Why?
|
| Models, Molecular | 2 | 2003 | 5439 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1991 | 1726 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2004 | 193 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 2009 | 3673 | 0.010 |
Why?
|
| Sesquiterpenes | 1 | 2003 | 176 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3778 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2003 | 283 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2008 | 3615 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 613 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2003 | 429 | 0.010 |
Why?
|
| Chromosome Segregation | 1 | 2003 | 235 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 506 | 0.010 |
Why?
|
| Centrosome | 1 | 2003 | 209 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 80636 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 638 | 0.010 |
Why?
|
| Karyopherins | 1 | 2002 | 132 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5305 | 0.010 |
Why?
|
| Kinetics | 2 | 2003 | 6374 | 0.010 |
Why?
|
| Skin | 1 | 1995 | 4484 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 714 | 0.010 |
Why?
|
| Retroviridae | 1 | 2003 | 850 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2004 | 624 | 0.010 |
Why?
|
| Lung | 3 | 1995 | 10000 | 0.010 |
Why?
|
| Histone Chaperones | 1 | 2001 | 83 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2002 | 389 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2002 | 435 | 0.010 |
Why?
|
| Leucine | 1 | 2002 | 548 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 540 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15936 | 0.010 |
Why?
|
| Threonine | 1 | 2001 | 271 | 0.010 |
Why?
|
| Peptides | 2 | 2003 | 4358 | 0.010 |
Why?
|
| Monocytes | 1 | 1989 | 2570 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2002 | 778 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 619 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 1999 | 104 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 2000 | 231 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 1999 | 42 | 0.010 |
Why?
|
| Ubiquitins | 1 | 2000 | 366 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2002 | 733 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2002 | 9539 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1999 | 621 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1999 | 315 | 0.010 |
Why?
|
| United States | 1 | 2006 | 72334 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 412 | 0.010 |
Why?
|
| Genes, Wilms Tumor | 1 | 1998 | 92 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 915 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41487 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1990 | 3396 | 0.010 |
Why?
|
| Wound Healing | 1 | 2008 | 2805 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 1998 | 184 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1989 | 4431 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 441 | 0.010 |
Why?
|
| Mitogens | 1 | 1997 | 230 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 1989 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1996 | 162 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 1996 | 70 | 0.010 |
Why?
|
| Exons | 1 | 2002 | 2391 | 0.010 |
Why?
|
| Cerebellum | 1 | 2004 | 1501 | 0.010 |
Why?
|
| Ploidies | 1 | 1996 | 285 | 0.010 |
Why?
|
| Seeds | 1 | 1996 | 122 | 0.010 |
Why?
|
| Chromosome Mapping | 2 | 1994 | 4615 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6863 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2003 | 2203 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1997 | 473 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 1998 | 568 | 0.010 |
Why?
|
| Cell Differentiation | 3 | 2000 | 11528 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1991 | 3613 | 0.010 |
Why?
|
| Virulence | 1 | 1999 | 1303 | 0.010 |
Why?
|
| Cell Separation | 1 | 2001 | 1720 | 0.010 |
Why?
|
| Adenovirus E2 Proteins | 1 | 1994 | 8 | 0.010 |
Why?
|
| E2F2 Transcription Factor | 1 | 1994 | 35 | 0.010 |
Why?
|
| E2F3 Transcription Factor | 1 | 1994 | 36 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1738 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 1999 | 1129 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 2192 | 0.010 |
Why?
|
| Genes, Suppressor | 1 | 1993 | 47 | 0.010 |
Why?
|
| Gene Library | 1 | 1996 | 1059 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1999 | 1176 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 2047 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1994 | 346 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1994 | 343 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 1693 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 1992 | 27 | 0.010 |
Why?
|
| Deferoxamine | 1 | 1993 | 155 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1206 | 0.010 |
Why?
|
| Nocodazole | 1 | 1992 | 95 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1992 | 299 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1992 | 207 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1993 | 303 | 0.010 |
Why?
|
| Estrogens | 1 | 1999 | 1522 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1992 | 133 | 0.010 |
Why?
|
| Mink | 1 | 1991 | 31 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 1141 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1991 | 777 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1844 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1999 | 2208 | 0.010 |
Why?
|
| Thrombospondins | 1 | 1991 | 193 | 0.010 |
Why?
|
| Point Mutation | 1 | 1995 | 1595 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1991 | 286 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2688 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1997 | 1667 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1991 | 532 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 21012 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1992 | 694 | 0.000 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 2510 | 0.000 |
Why?
|
| RNA-Binding Proteins | 1 | 1997 | 1897 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1993 | 1173 | 0.000 |
Why?
|
| Oligonucleotides | 1 | 1991 | 582 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8181 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1997 | 2911 | 0.000 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1994 | 1363 | 0.000 |
Why?
|
| Germ-Line Mutation | 1 | 1995 | 1858 | 0.000 |
Why?
|
| Interleukin-2 | 1 | 1993 | 1889 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1994 | 4243 | 0.000 |
Why?
|
| DNA Methylation | 1 | 1997 | 4398 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1996 | 3847 | 0.000 |
Why?
|
| Kidney | 1 | 1998 | 7048 | 0.000 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1995 | 3164 | 0.000 |
Why?
|